Literature DB >> 24158143

Interferon-γ and interleukin-4 detected in serum and saliva from patients with oral lichen planus.

Wen-Zhao Liu1, Ming-Jing He2, Long Long2, Dong-Liang Mu2, Ming-Shu Xu2, Xue Xing2, Xin Zeng2, Ga Liao2, Hong-Xia Dan2, Qian-Ming Chen2.   

Abstract

Our previous salivary study had demonstrated an apparent T helper 2 (Th2)-predominance in saliva of oral lichen planus (OLP) patients and suggested a potential of salivary interleukin-4 (IL-4) as a biomarker for monitoring disease severity. To further determine the consistency of Th1/Th2 bias of OLP, this study investigated the expression profile of interferon-γ (IFN-γ) and IL-4 in serum and the relationship of the serum levels of these cytokines with their saliva partners. Sixty ethnic Chinese patients with OLP (40 of the erythematous/ulcerative form and 20 of the reticular form) were recruited for this study, with 40 age-sex-matched healthy volunteers as control group. IFN-γ and IL-4 levels in serum and paired saliva samples were screened by enzyme-linked immunosorbent assay. OLP patient showed a low-level IFN-γ but high-level IL-4 expression profile in both serum and saliva, with a lower IFN-γ/IL-4 ratio. Serum IL-4 level in the erythematous/ulcerative group was significantly higher than that in the reticular group. Serum levels of IFN-γ and IL-4 were significantly and positively correlated with their saliva partners. These results provided more evidence for Th2 cytokine-predominant immune imbalance in OLP, as well as the potential of IL-4 as the biomarker for monitoring severity of OLP.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24158143      PMCID: PMC3967304          DOI: 10.1038/ijos.2013.74

Source DB:  PubMed          Journal:  Int J Oral Sci        ISSN: 1674-2818            Impact factor:   6.344


INTRODUCTION

The signature cytokines of distinct T-cell subsets and the transcriptional regulation of T-cell differentiation are indicated to be of fundamental importance in mucosal immunity.[1] A key component of mucosal immune response is mediated by CD4+ T lymphocytes that can differentiate into functionally distinct subsets. Whereas T helper 1 (Th1) cells secrete the cytokines interferon-γ (IFN-γ) and tumor-necrosis factor-α, Th2 cells secrete interleukin-4 (IL-4), IL-5, IL-9 and IL-13. The mutually antagonistic effects of IFN-γ and IL-4, the principal cytokines of Th1 and Th2 cells respectively, regulate Th1/Th2 balance and subsequent polarization.[2] A close relationship between Th1/Th2 imbalance and pathogenesis of mucosal inflammatory diseases has been well demonstrated, such as Th2-predominence in allergic asthma[3] and Th1-predominence in Crohn's disease.[4] Skewing of Th1/Th2 balance is critical for the clinical outcome and may become a new therapeutic strategy for immunologic disorders.[4,5,6] Oral lichen planus (OLP) is a chronic inflammatory oral mucosal disease characterized by a T lymphocyte-mediated immune response, affecting about 0.5%–2% of the world population and persisting up to more than 20 years without spontaneous remission.[7,8] Th1 and Th2 type cytokines in OLP, especially IFN-γ and IL-4, have been studied extensively with several research media,[9,10,11,12,13,14] but the conclusions of these studies were quite controversial, probably due to the small sample size. Our previous study with relatively large sample size demonstrated a Th2-predominant expression profile in saliva of OLP patients.[15] To further determine the systemic Th1/Th2 expression pattern and the consistency of Th1/Th2 bias between saliva and serum in OLP, we performed the current study, investigating the expression profile of IFN-γ and IL-4 in sera and saliva simultaneously collected from the OLP patients and healthy controls.

MATERIALS AND METHODS

Subjects

A sum of 60 ethnic Chinese patients (female/male: 35/25; mean age: 45±16 years old) clinically and histopathologically diagnosed as OLP, were recruited in this study, according to clinical classification[7] and the definition of OLP by the World Health Organization. Forty of the OLP patients were classified as the erythematous/ulcerative subtype, while the other 20 were classified as reticular subtype. Forty healthy volunteers (female/male: 21/19; mean age: 42±15 years old), which were age–sex-matched to the patients of erythematous/ulcerative group, were recruited as control group. All subjects were non-smokers who neither had any severe systemic disorders (such as diabetes mellitus, chronic hepatitis C, etc.), nor any soft tissue lesions in the oral cavity. Subjects with periodontitis were excluded from the current study. And those with gingivitis were subjected to supragingival scaling first and the sample collection was performed after the inflammation was resolved. Moreover, none of the participants received any medical treatments within at least 90 days prior to the sample collection. This study was carried out under the approval and supervision of the Committee for the Use of Human Subjects in Research in Sichuan University (approval number: WCHSIEC-D-2008-00002); informed consents were obtained from all the participants.

Collection of samples

Blood samples were collected between 8:00 and 10:00 a.m. from subjects. The blood sample was allowed to clot for 30 min before the separation of the serum. Serum was separated from blood cells by centrifugation at 1 000g for 5 min. Whole unstimulated saliva sample, which was paired with serum sample from each participant, was collected simultaneously as described in our previous study.[15] After centrifugation at 3 500g for 20 min, the clarified supernatant of the saliva was collected. All the samples were stored at −80 °C for further use.

Cytokines assays

Serum and saliva samples were kept at room temperature for about 1 h to defrost completely before assays. IFN-γ (sensitivity: 8 ng⋅L−1) and IL-4 (sensitivity: 10 ng⋅L−1) concentrations were determined in duplicate using enzyme-linked immunosorbent assay kits (R&D Systems, Minneapolis, MN, USA). The standard curve range used in this study was 3.9–250 ng⋅L−1 for IFN-γ and 7.8–500 ng⋅L−1 for IL-4. Data were read with a spectrophotometer (Sirio; Seac, Florence, Italy) at 450 nm, the concentrations of IFN-γ and IL-4 in the samples were determined by extrapolating from the standard curve created by plotting the absorbance of the standards versus corresponding concentrations, and results were expressed as ng⋅mL−1.

Statistical analysis

Statistical Package for Social Science (SPSS 13.0 for Windows; SPSS Inc., Chicago, IL, USA) software was used to analyze the data. Results were expressed as mean±standard deviation. Two-sample (Student's) t-tests were used for pairwise comparison of OLP group and control group. One-way analysis of variance was used to compare the differences between the two OLP subtype groups and between the each OLP subtype group and the control group. Additionally, correlation of the IFN-γ and IL-4 expression levels in serum and paired salivary samples in OLP patients was assessed by Pearson's correlation. P<0.05 was considered statistically significant.

RESULTS

Serum levels of IFN-γ, IL-4 and IFN-γ/IL-4 ratio

As shown in Table 1, serum IFN-γ level of OLP patients was markedly lower than control group (P<0.001). When OLP patients were divided into erythematous/ulcerative subgroup and reticular subgroup, IFN-γ levels demonstrated the same tendency, compared with control group (P<0.001; P=0.006; Figure 1), while there was no significant difference of IFN-γ level between the two different subtypes of OLP (P=0.086).
Table 1

Expression of IFN-γ and IL-4 in serum in OLP patients

ItemsIFN-γ /(ng⋅L−1)IL-4 /(ng⋅L−1)IFN-γ/IL-4
OLP (n=60)a21.057±11.860*20.545±3.482*1.048±0.612*
 Erythematous/ulcerative (n=40)19.492±3.121*b21.188±3.511*0.925±0.606*
 Reticular (n=20)24.185±7.455*19.259±3.121 *1.296±0.472*
Control (n=40)31.935±10.86715.917±2.8972.130±1.013
OLP vs. controlP<0.001P<0.001P<0.001
 Erythematous/ulcerative OLP vs. controlP<0.001P<0.001P<0.001
 Reticular OLP vs. controlP=0.006P<0.001P<0.001
Erythematous/ulcerative OLP vs. reticular OLPP=0.086P=0.042P=0.014

IFN, interferon; IL, interleukin; OLP, oral lichen planus.

*P<0.05 when compared with the control group.

Mean value of OLP group were calculated based on the erythematous/ulcerative group and reticular group.

Seven of the samples had a value below the assay detection range, and their values were estimated by the regression equation of standard curve.

Figure 1

IFN- OLP, oral lichen planus; rOLP, reticular oral lichen planus; eOLP, erythematous/ulcerative oral lichen planus.

On the contrary, serum IL-4 level of OLP patients was higher than control group (P<0.001). IL-4 levels in erythematous/ulcerative subgroup and reticular subgroup demonstrated the same tendency compared with control group (P<0.001; P<0.001; Figure 2). Furthermore, the mean serum IL-4 level was higher in erythematous/ulcerative group than in reticular OLP group (P=0.042).
Figure 2

IL-4 levels of serum saliva in OLP patients. IL, interferon; OLP, oral lichen planus; rOLP, reticular oral lichen planus; eOLP, erythematous/ulcerative OLP, oral lichen planus.

Serum IFN-γ/IL-4 ratio was lower in OLP group than control group (P<0.001). Among subtypes of OLP, this ratio was lower in erythematous/ulcerative group than in reticular group (P=0.014).

Saliva levels of IFN-γ, IL-4 and IFN-γ/IL-4 ratio

As shown in Table 2, saliva IFN-γ level of OLP patients was significantly lower than control group (P<0.001), while there was no significant difference of IFN-γ level between the two different subtypes of OLP (P=0.324; Figure 1).
Table 2

Expression of IFN-γ and IL-4 in saliva from OLP patients

ItemsIFN-γ /(ng⋅L−1)IL-4 /(ng⋅L−1)IFN-γ/IL-4
OLP (n=60)a22.327±11.260*21.564±3.422*1.059±0.559*
 Erythematous/ulcerative (n=40)21.439±12.567*b22.317±3.779*0.983±0.606*
 Reticular (n=20)24.104±8.037*20.059±1.8631.213±0.424*
Control (n=40)33.517±14.96819.624±1.2211.728±0.821
OLP vs. controlP<0.001P<0.001P<0.001
 Erythematous/ulcerative OLP vs. controlP<0.001P<0.001P<0.001
 Reticular OLP vs. controlP=0.011P=0.282P=0.011
Erythematous/ulcerative OLP vs. reticular OLPP=0.324P=0.003P=0.094

IFN, interferon; IL, interleukin; OLP, oral lichen planus.

*P<0.05 when compared with the control group.

Mean value of OLP group were calculated based on the erythematous/ulcerative group and reticular group.

Two of the samples had a value below the assay detection range, and their values were estimated by the regression equation of standard curve.

Saliva IL-4 level of OLP patients or patients with erythematous/ulcerative OLP was higher than control group (both P<0.001; Figure 2). Furthermore, the mean saliva IL-4 level was higher in erythematous/ulcerative group than in reticular OLP group (P=0.003). There was no significant difference of IL-4 level between patients with reticular OLP and healthy controls (P=0.282). Saliva IFN-γ/IL-4 ratio was lower in OLP group than control group (P<0.001), with no significant difference between two subtypes of OLP (P=0.094).

Correlations of IFN-γ and IL-4 levels between serum and saliva

Saliva levels of IFN-γ and IL-4 in OLP patients were significantly higher than their serum partners (P=0.005 and P=0.007, respectively). A significant positive correlation of cytokine levels between serum and saliva was found in OLP patients (Figure 3), either in the whole group (IFN-γ: correlation coefficient=0.954, P<0.001; IL-4: correlation coefficient=0.696, P<0.001) or the erythematous/ulcerative subgroup (IFN-γ: correlation coefficient=0.985, P<0.001; IL-4: correlation coefficient=0.682, P<0.001) and reticular subgroup (IFN-γ: correlation coefficient=0.797, P<0.001; IL-4: correlation coefficient=0.710, P<0.001). Meanwhile, IFN-γ/IL-4 ratio in serum from OLP patient was also positively correlated with its saliva partner (whole OLP group: correlation coefficient=0.923, P<0.001; erythematous/ulcerative subgroup: correlation coefficient=0.965, P<0.001; reticular subgroup: correlation coefficient=0.758, P<0.001).
Figure 3

Correlations of cytokines levels between serum and saliva in OLP patients. OLP, oral lichen planus.

DISCUSSION

Cytokines but not cytokine-secreted cells drive and maintain the in vivo immune response. IFN-γ and IL-4, the most characteristic Th1 and Th2 cytokines, respectively, regulate the T-cell differentiation and Th1/Th2 balance involved in physiological and pathological immune processes. IFN-γ is involved in the maturation and activation of CD8+ cytotoxic T cell and maintaining the expression of major histocompatibility class II molecules, thus participating in keratinocyte apoptosis and disease chronicity of OLP.[16] IL-4, on the other hand, is necessary for Th2 cell differentiation and plays an important role in regulation of antibody production and humoral immune response.[1] As IFN-γ inhibits the expression of Th2 cytokines such as IL-4, and vice versa, the IFN-γ/IL-4 cytokine ratio is considered to be a simple and direct indicator of Th1/Th2 balance.[17] Being consistent with our previous salivary study, the present study demonstrated lower IFN-γ but higher IL-4 expression levels in serum of OLP patient, with a lower IFN-γ/IL-4 ratio when compared to healthy controls. Taken together, our data indicated an imbalance favoring Th2 predominance in OLP. Although the precise etiology of OLP is still unknown, it has been widely accepted that immunological aberrances are very critical among the multiple etiological factors.[9,18] The role of Th1/Th2 imbalance in the pathogenesis of OLP has been studied extensively in the past few years. Based on the expression of Th1 cytokines (IFN-γ and tumor-necrosis factor-α) but not IL-4 and IL-10 by T cells in the lymphocytic infiltrate of OLP lesion and the pathological hypothesis of OLP that intra-epithelial Th1-activated autocytotoxic CD8+ T cells trigger keratinocyte apoptosis, Sugerman et al.[10,19] suggested that OLP was characterized by Th1 cytokine bias. However, simultaneous expression of Th1 and Th2 cytokines are detected in OLP local lesion and tissue transudates.[13,14] Furthermore, saliva, serum and peripheral blood mononuclear cells from OLP patients present a mixed general expression profile of both Th1 and Th2 cytokines.[11,14,15,20] There is no doubt that both Th1 and Th2 immune responses are involved in the development of OLP. Calculating and comparing the ratio of Th1/Th2-related cytokine and transcription factor expression might provide a clue for the exploration of Th1/Th2 imbalance in OLP etiology. In our studies, as well as a study by Rhodus and colleagues,[13,15] a Th2 skew in OLP patients was demonstrated. Nevertheless, in another study, in which the expression of specific transcription factors of Th1 and Th2 was examined, a predominant role of Th1-type immune response was implicated.[21] Yet in another study, which calculated the IFN-γ/IL-4 ratio in lesional tissue and unstimulated whole saliva, the expression of both cytokines were elevated and the IFN-γ/IL-4 ratio showed no significant difference in OLP patients and healthy controls. These controversies might partly be caused by the difference of patients, research methods or sample sizes, but it also implied that there might be some mechanisms, such as the role of regulatory T cells[22] and new subsets of Th cells,[23] in the etiology of OLP other than Th1/Th2 imbalance. OLP has various clinical forms without accepted consensual criteria for the evaluation of severity. Patients are usually evaluated according to the clinical and pathological manifestations.[24] Previous investigations indicated that the erythematous/ulcerative subtype seemed to cause more serious symptoms such as pain and bleeding, and be at risk for future malignant transformation compared with reticular subtype.[25] In the current study, though the expression of both cytokines was significantly different in OLP patients and healthy controls, only IL-4 level (both in serum and in saliva) showed significant difference in between two subtypes of OLP. These results indicated that IL-4 might be detrimental for OLP clinical outcome and a fine biomarker reflecting the severity of OLP. There were strong correlations of IFN-γ and IL-4 levels and ratio between serum and saliva from OLP patients. It suggested that cytokine expression in OLP was consistent in saliva and serum, detection of salivary cytokines could reflect systemic cytokine expression profile in OLP. Furthermore, we observed that the salivary concentrations of the cytokines from patients with OLP were higher than their serum partners, probably due to production of cytokines from the inflammatory infiltration and keratinocytes in OLP lesion and/or dysfunction of the structural barriers in oral mucosa. It was consistent with the study by Zhang et al.[26] With the advantages of easy access and non-invasive collection by individuals with modest training, whole saliva provides a cost-effective approach for the repetitious disease monitoring and the screening of large populations in studies of systemic diseases and especially oral diseases. It might be a better routine substitute for other OLP test means to reflect the severity of OLP by detecting the salivary IL-4 level.[27] It is necessary to note, limited by the detection range of the enzyme-linked immunosorbent assay kit, some IFN-γ detected values in the erythematous/ulcerative OLP group were below the detection range and estimated by the regression equation of standard curve, which might not be accurate. A more sensitive assay should be need for the further studies. In general, our current study, together with our previous study, identified the Th2 cytokine-predominant immune imbalance in OLP and indicated that IL-4 level might be in association with severity of OLP.
  27 in total

Review 1.  The role of Th1/Th2 polarization in mucosal immunity.

Authors:  Markus F Neurath; Susetta Finotto; Laurie H Glimcher
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

2.  Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease.

Authors:  Kamran Ghoreschi; Peter Thomas; Susanne Breit; Martin Dugas; Reinhard Mailhammer; Willem van Eden; Ruurd van der Zee; Tilo Biedermann; Jörg Prinz; Matthias Mack; Ulrich Mrowietz; Enno Christophers; Detlef Schlöndorff; Gerd Plewig; Christian A Sander; Martin Röcken
Journal:  Nat Med       Date:  2002-12-02       Impact factor: 53.440

Review 3.  The diagnostic applications of saliva--a review.

Authors:  Eliaz Kaufman; Ira B Lamster
Journal:  Crit Rev Oral Biol Med       Date:  2002

4.  Th1 cytokines in oral lichen planus.

Authors:  Ambereen Khan; Camile S Farah; Neil W Savage; Laurence J Walsh; Doug J Harbrow; Philip B Sugerman
Journal:  J Oral Pathol Med       Date:  2003-02       Impact factor: 4.253

Review 5.  Oral lichen planus: update on etiopathogenesis, diagnosis and treatment.

Authors:  Vito Crincoli; Maria Beatrice Di Bisceglie; Michele Scivetti; Alberta Lucchese; Simona Tecco; Felice Festa
Journal:  Immunopharmacol Immunotoxicol       Date:  2010-07-06       Impact factor: 2.730

6.  Expression of T-bet and GATA-3 in peripheral blood mononuclear cells of patients with oral lichen planus.

Authors:  Rui Lu; Gang Zhou; Gefei Du; Xueyi Xu; Jianguang Yang; Jingyu Hu
Journal:  Arch Oral Biol       Date:  2010-12-15       Impact factor: 2.633

Review 7.  The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients.

Authors:  Drore Eisen
Journal:  J Am Acad Dermatol       Date:  2002-02       Impact factor: 11.527

Review 8.  Oral lichen planus: causes, diagnosis and management.

Authors:  P B Sugerman; N W Savage
Journal:  Aust Dent J       Date:  2002-12       Impact factor: 2.291

9.  Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective?

Authors:  Diana Gómez; Paula A Correa; Luis Miguel Gómez; José Cadena; José F Molina; Juan-Manuel Anaya
Journal:  Semin Arthritis Rheum       Date:  2004-06       Impact factor: 5.532

Review 10.  The pathogenesis of oral lichen planus.

Authors:  P B Sugerman; N W Savage; L J Walsh; Z Z Zhao; X J Zhou; A Khan; G J Seymour; M Bigby
Journal:  Crit Rev Oral Biol Med       Date:  2002
View more
  14 in total

Review 1.  Detection of inflammatory biomarkers in saliva and urine: Potential in diagnosis, prevention, and treatment for chronic diseases.

Authors:  Sahdeo Prasad; Amit K Tyagi; Bharat B Aggarwal
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-24

2.  Expression and clinical significance of periostin in oral lichen planus.

Authors:  Zhi-Rui Zhang; Li-Ya Chen; Hong-Yan Qi; Shao-Hua Sun
Journal:  Exp Ther Med       Date:  2018-04-03       Impact factor: 2.447

3.  A novel formulation of Mtb72F DNA vaccine for immunization against tuberculosis.

Authors:  Razieh Dalirfardouei; Mohsen Tafaghodi; Zahra Meshkat; Adel Najafi; Aida Gholoobi; Maryam Sadat Nabavinia; Samineh Sajedifar; Mojtaba Meshkat; Ali Badiee; Mohammad Ramezani; Abdol-Reza Varasteh; Mahboubeh Naderinasab
Journal:  Iran J Basic Med Sci       Date:  2020-06       Impact factor: 2.699

4.  The Activation of NF-κB in Infiltrated Mononuclear Cells Negatively Correlates with Treg Cell Frequency in Oral Lichen Planus.

Authors:  Dunfang Zhang; Jiayi Wang; Zhangwei Li; Min Zhou; Qianming Chen; Xin Zeng; Yu Chen
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

5.  [Expression of interleukin-12 and interleukin-27 proteins and immune status in serum of patients with oral lichen planus].

Authors:  Yunying Huang; Sn Zhou; Yang Cai
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2016-04

6.  Salivary Interferon Gamma and Interleukin-4 Levels in Patients Suffering from Oral Lichen Planus.

Authors:  Hossein Malekzadeh; Maryam Robati; Hojatollah Yousefimanesh; Mehri Ghafourian Boroujerdnia; Reza Nadripour
Journal:  Cell J       Date:  2015-10-07       Impact factor: 2.479

7.  Association between polymorphisms in interleukins and oral lichen planus: A meta-analysis.

Authors:  Quan Shi; Tong Zhang; Na Huo; Yang Huang; Juan Xu; Hongchen Liu
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

8.  Myeloid dendritic cells stimulated by thymic stromal lymphopoietin promote Th2 immune responses and the pathogenesis of oral lichen planus.

Authors:  Masaki Yamauchi; Masafumi Moriyama; Jun-Nosuke Hayashida; Takashi Maehara; Noriko Ishiguro; Keigo Kubota; Sachiko Furukawa; Miho Ohta; Mizuki Sakamoto; Akihiko Tanaka; Seiji Nakamura
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240

9.  Salivary and Serum Interferon-Gamma/Interleukin-4 Ratio in Oral Lichen Planus Patients: A Systematic Review and Meta-Analysis.

Authors:  Hamid Reza Mozaffari; Maryam Molavi; Pia Lopez-Jornet; Masoud Sadeghi; Mohsen Safaei; Mohammad Moslem Imani; Roohollah Sharifi; Hedaiat Moradpoor; Amin Golshah; Ladan Jamshidy
Journal:  Medicina (Kaunas)       Date:  2019-06-08       Impact factor: 2.430

10.  Serum cytokine profile and clinicopathological findings in oral lichen planus, oral lichenoid lesions and stomatitis.

Authors:  Kristine Roen Larsen; Jeanne Duus Johansen; Jesper Reibel; Claus Zachariae; Anne Marie Lynge Pedersen
Journal:  Clin Exp Dent Res       Date:  2017-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.